First Horizon Advisors, Inc. Ptc Therapeutics, Inc. Transaction History

First Horizon Advisors, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$38.16 - $48.86 $1,030 - $1,319	27 Added 32.14%	111 $5,000
Q4 2022 Feb 10, 2023	SELL	$33.53 - $54.79 $2,984 - $4,876	-89 Reduced 51.45%	84 $3,000
Q3 2022 Nov 09, 2022	BUY	$41.85 - $53.85 $41 - $53	1 Added 0.58%	173 $9,000
Q2 2022 Aug 02, 2022	SELL	$25.6 - $45.23 $1,920 - $3,392	-75 Reduced 30.36%	172 $6,000
Q1 2022 May 10, 2022	BUY	$33.33 - $44.6 $66 - $89	2 Added 0.82%	247 $9,000
Q2 2021 Aug 09, 2021	BUY	$37.95 - $49.37 $75 - $98	2 Added 0.82%	245 $10,000
Q1 2021 May 11, 2021	BUY	$46.8 - $68.92 $1,310 - $1,929	28 Added 13.02%	243 $11,000
Q4 2020 Feb 11, 2021	BUY	$47.96 - $67.64 $1,486 - $2,096	31 Added 16.85%	215 $13,000
Q2 2020 Jul 31, 2020	BUY	$42.56 - $54.98 $638 - $824	15 Added 8.88%	184 $9,000
Q1 2020 May 05, 2020	BUY	$32.37 - $59.36 $5,470 - $10,031	169 New	169 $7,000

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.31B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on First Horizon Advisors, Inc. with notifications on news.